Fri, Aug 22, 2014, 7:46 AM EDT - U.S. Markets open in 1 hr 44 mins

Recent

% | $
Quotes you view appear here for quick access.

BioTime, Inc. Message Board

  • a__1 a__1 Apr 23, 1998 11:41 AM Flag

    Management Team and BTIM/CMSI Rants

    Does anyone have any comment on how confident they are in BTIM's management team? I think it is worrisome for BTIM's investors that so much of its board is composed of BTIM's management. Does anyone know how involved BTIM's management was with the management of CMSI? Judging by CMSI's stock history, any significant involvent is not encouraging. I feel sorry for anyone who has been long in CMST's stock for a "long" time. Now, though, the price is so low, I think it would be a poor short.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • are short either btim or cmsi? if you don't mind me asking.

      • 1 Reply to fedspeak
      • I don't own either btim or cmsi. For me, there is a price above which it is a good short and below which it is a bargain
        long. The hype, emotion, lack of management experience, and history with CMSI are reasons to short this stock. In general, though
        it may be a good product--certainly there is a large market for blood and its substitutes. I would consider getting in long at
        single digits, but I certainly would not make it a major part of my portfolio and I would want to spread my risk around this
        sector.

        People seem hyped about Abbott as a partner. Abbott is NOT a market leader in this area. It got its ass kicked by Baxter about 20 years ago and has never caught up. That's not to say that being partnered with Abbott is a bad thing, it's definitely a plus.

    • Obviously, this doesn't have anything to do with BTIM's long term potential or basic science, and I'm not even sure whether
      it is just perception or reflects reality, but it seems like BTIM had an over abundance of press releases with respect to their
      Phase III hextend trial, e.g. "BTIM has finished its trial", "BTIM will present its results at xxx meeting", "BTIM is unblinding
      its results", etc. There's no beef here. In terms of the blood substite-like and blood-safety companies I've looked at, BTIM is
      clearly the most hype-prone, and I don't think this is such a good thing. Biotime may have a good product, but so much hype breeds
      unrealistic expectations, and anytime those expectations aren't met, the stock takes a bigger hit than it should.

 
BTX
2.85-0.04(-1.38%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.